Ascendis Pharma A/S
ASND · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60,990 | -$38,856 | -$94,626 | -$38,469 |
| Dep. & Amort. | $4,019 | $4,308 | $4,545 | $4,475 |
| Deferred Tax | $3,617 | $3,848 | $1,061 | $1,085 |
| Stock-Based Comp. | $30,636 | $30,022 | $25,558 | $26,221 |
| Change in WC | $24,642 | -$44,027 | $50,488 | -$44,393 |
| Other Non-Cash | $229 | $37,364 | -$1,339 | -$36,095 |
| Operating Cash Flow | $2,153 | -$7,341 | -$14,313 | -$87,176 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$53 | -$4,338 | -$703 | -$419 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$1 |
| Other Inv. Act. | $0 | $0 | $0 | $36 |
| Investing Cash Flow | -$53 | -$4,338 | -$703 | -$384 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,571 | -$5,487 | -$3,066 | -$2,947 |
| Stock Issued | $0 | $0 | $0 | $19,291 |
| Stock Repurch. | $0 | $0 | -$17,396 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45,425 | $12,468 | $2,438 | -$16,257 |
| Financing Cash Flow | $38,854 | $6,981 | -$18,024 | $87 |
| Forex Effect | $4,092 | -$19,179 | -$8,580 | $21,501 |
| Net Chg. in Cash | $45,046 | -$23,877 | -$41,620 | -$65,972 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $494,046 | $517,923 | $559,543 | $625,515 |
| End Cash | $539,092 | $494,046 | $517,923 | $559,543 |
| Free Cash Flow | $2,100 | -$11,679 | -$15,016 | -$87,559 |